Report Scope:
The scope of the report includes infectious disease drugs applications, industries, markets and companies in China. The markets for infectious disease drugs are given for the years 2015, 2016 and 2021.
The report covers the Chinese market for both communicable and noncommunicable infectious disease drugs. In this report, communicable infectious diseases only refer to the 39 statutory communicable diseases stated by the National Health and Family Planning Commission of the People's Republic of China (NHFPC). They include viral hepatitis, pulmonary tuberculosis, syphilis, bacillary/amebic dysentery, gonorrhea, scarlet fever, brucellosis, acquired immunodeficiency syndrome (AIDS), hand-foot-and-mouth disease, infectious diarrhea, influenza, and epidemic parotitis.
In this report, China is referred to as Mainland China. It does not include Hong Kong, Macao and Taiwan. Mainland China has a total of 31 province-level regions, including 22 provinces, four province-level municipalities (cities) and five province-level autonomous regions. Important geographic markets will be discussed, including Beijing, Shanghai, Guangdong and others.
More than 100 Chinese companies in the infectious disease drug industry are profiled in this report.
Report Includes:
- An overview of the Chinese market for infectious disease drugs.
- Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Discussion of the increasing concern regarding antibiotic-resistant organisms and their sometimes-fatal effects on humans.
- Examination of technological developments, future trends, and emerging opportunities.
- Assessments of the current state of infectious diseases on a global basis, broken down by type of disease (i.e., bacterial, viral, parasitic, and fungal) and appropriate treatments, both current and anticipated, and by geographic region.
- Profiles of major players in the field of infectious disease treatments.
Infectious Disease Drugs: The Chinese Market
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing the Study
Scope of Report
Intended Audience
Methodology
Information Sources
Analysts' Credentials
Related Bcc Research Reports
Bcc Research Website
Disclaimer
Chapter 2 Summary
Largest and Fastest-Growing Markets
Largest Infectious Disease Drug Markets
Fast-Growing Infectious Disease Drug Markets
Laws, Regulations and Targets
Pharmaceutical Administration Law of the People's Republic of China
Procurement and Bidding Management of the China Food and Drug Adminitration
Administrative Measures for the Clinical Use of Antibacterial Drugs
Limitation of Antibacterial Drugs
Chapter 3 the Chinese Drug Market
Chinese Drug Market By Sales Channels
Supply Chain and Pricing Structure
Hospitals
Retailers
Retail Market
Chinese Drug Retail Market By Drug Type
Chinese Traditional Drugs In the Retail Market
Chemical and Biological Drugs In the Chinese Retail Market
Chinese Retail Market By Drug Stores
Chinese Hospital Drug Market
Chinese Traditional Drugs Sold In Hospitals
Chemical and Biological Drugs Sold In Hospitals
Chinese Drug Market By Drug Type
the Chinese Traditional Drug Market By Major Sales Channels
the Chinese Chemical and Biological Drug Market By Major Sales Channels
Chapter 4 Chinese Infectious Disease Drug Market By Disease
Most Common 39 Communicable Diseases
Communicable Diseases In China
Category A Communicable Diseases
Category B Communicable Diseases
Category C Communicable Diseases
History
the Chinese Communicable Disease Drug Market By Disease Type
Viral Hepatitis
Pulmonary Tuberculosis
Aids
Infective Keratitis and Conjunctivitis
Other Infectious Diseases
Acinetobacter Infections
Actinomycosis
Amoebiasis
Anthrax
Aspergillosis
Bacterial Pneumonia
Viral Pneumonia
Chapter 5 Chinese Infectious Disease Drug Market By Products
Top 30 and Top 100 Infectious Disease Drugs In China
Entecavir
Chinese Entecavir Market By Sales Channels
Chinese Entecavir Market By Manufacturers
Piperacillin-Tazobactam (Injection)
Meropenem (Injection)
Chinese Meropenem Market By Sales Channels
Chinese Meropenem Market By Drugmakers
Cefperazone-Sulbactam (Injection)
Chinese Cefperazone-Sulbactam Market By Sales Channels
Chinese Cefperazone-Sulbactam Market By Drugmakers
Levofloxacin (Injection)
Chinese Levofloxacin Market By Sales Channels
Injective Levofloxacin
Oral Levofloxacin
Chinese Injective Levofloxacin Market By Drugmakers
Cefoperazone-Tazobactam (Injection)
Cefuroximee (Injection)
Cefotiam (Injection)
Chinese Cefotiam Market By Sales Channels
Chinese Injective Cefotiam Market By Drugmakers
Cefathiamidine (Injection)
Chinese Cefathiamidine Market By Sales Channels
Chinese Injective Cefathiamidine Market By Drugmakers
Imipenem-Cilastatin (Injection)
Chinese Imipenem/Cilastatin Market By Sales Channels
Chinese Injective Imipenem/Cilastatin Market By Drugmakers
Voriconazole (Injection)
Chinese Injective Voriconazole Market By Sales Channels
Chinese Injective Voriconazole Market By Drugmakers
Moxifloxacin (Injection and Tablets)
Chinese Moxifloxacin Market By Sales Channels
Chinese Moxifloxacin Market By Drugmakers
Cefoxitin (Injection)
Chinese Injective Cefoxitin Market By Sales Channels
Chinese Injective Cefoxitin Market By Drugmakers
Latamoxef (Injection)
Chinese Injective Latamoxef Market By Sales Channels
Chinese Injective Latamoxef Market By Drugmakers
Ceftriaxone (Injection)
Chinese Injective Ceftriaxone Market By Sales Channels
Chinese Injective Ceftriaxone Market By Drugmakers
Adefovir
Chinese Adefovir Market By Sales Channels
Chinese Adefovir Market By Manufacturers
Lamivudine
Chinese Lamivudine Market By Sales Channels
Chinese Lamivudine Market By Manufacturers
Cefazolin (Injection)
Chinese Injective Cefazolin Market By Sales Channels
Chinese Injective Cefazolin Market By Drugmakers
Ceftazidime (Injection)
Chinese Injective Ceftazidime Market By Sales Channels
Chinese Injective Ceftazidime Market By Drugmakers
Telbivudine
Other Drugs
Cefixime
Amoxicillin-Clavulanate
Itraconazole
Cefaclor
Vidarabine (Injection)
Chinese Vidarabine Market By Sales Channels
Chinese Vidarabine Market By Manufacturers
Valacyclovir Tablets
Ganciclovir (Injection)
Foscarnet for Injection
Oseltamivir Tablets
Ribavirin
Chapter 6 Chinese Infectious Disease Drugs By Producers
Chapter 7 the Chinese Infectious Disease Drug Market By Sales Channels
Chinese Infectious Disease Drugs Retail Market
Chinese Infectious Disease Drugs Retail Market By Retailers
Chinese Infectious Disease Drugs Retail Market By Drugs
Cefixime
Entecavir
Adefovir
Chinese Hospital Market for Infectious Disease Drugs
City and County Hospitals
Town and Village Hospitals
Chapter 8 Chinese Infectious Disease Drug Market By Geography
Chinese Geography
Chinese Infectious Disease Drug Market By Geography
North China Infectious Disease Drug Market By Province
East China Infectious Disease Drug Market By Province
South China Infectious Disease Drug Market By Province
Middle China Infectious Disease Drug Market By Province
Northwest China Infectious Disease Drug Market By Province
Southwest China Infectious Disease Drug Market By Province
Northeast China Infectious Disease Drug Market By Province
Chinese Infectious Drug Market By Province
Chapter 9 Industry Structure and Market Strategies
Drugmakers
foreign Drugmakers
Government Relationship
First- and Second-Tier Cities
Sales Channels
Homegrown Drugmakers
Government Relationship
Third- and Fourth-Tier Cities
Sales Channels
Drug Wholesalers
Drug Retailers
Exclusive Distributors
Hospitals
Retailers
End Consumers
Chapter 10 Company Profiles
Anhui Biochem United Pharmaceutical Co. Ltd.
Bayer China Ltd.
Beijing Tong Ren Tang
Bristol-Myers Squibb (China) Investment Co. Ltd.
Chiatai Tianqing Pharmaceutical Group Co. Ltd.
China Pharmaceutical University Pharmaceutical Co. Ltd. (Cpu-Pharma)
Chongqing Kerui Pharmaceutical Co. Ltd.
Chongqing Lummy Pharmaceutical Co. Ltd.
Dashenlin
Dawnrays Pharmaceutical (Holdings) Ltd.
Ebang Pharmaceutical
Fujian Cosunter Pharmaceutical Co. Ltd.
Furen Huaiqingtang Pharmaceutical Co. Ltd.
Gsk China
Guangzhou Baiyunshan Pharmaceutical Holding Co. Ltd.
Guoda Drugstore
Harbin Pharmaceutical Group Holding Co. Ltd.
Hunan Qianjin Xiangjiang Pharmaceutical Industry Co. Ltd.
Hunan Xinhui Pharmaceutical Co. Ltd.
Jiangsu Wuzhong Pharmaceutical Group Corporation
Kelun Industry Group & Sichuan Kelun Pharmaceutical Co. Ltd.
Luoxin Pharmaceutical
Medfron
Msd China
North China Pharmaceutical Group
Panbiotic
Pfizer China
Qilu Pharmaceutical Co. Ltd.
Qingfeng Pharmaceutical Group
Reyoung Pharmaceutical Co. Ltd.
Roche China
Rundu Pharma
Shandong Lukang Pharmaceutical Co. Ltd.
Shandong Runze Pharmaceutical Co. Ltd.
Sumitomo Pharmaceuticals (Suzhou) Co. Ltd.
Tungshun Pharmaceutical
Waterstone Pharmaceuticals
Yongning Pharma
Youcare Pharmaceutical Group Co. Ltd.
Yung Shin Pharm. Ind. (Kunshan) Co. Ltd.
Zhejiang Hisun Pharmaceutical Co. Ltd.
Zhejiang Medicine Co. Ltd.
Zhijun Pharmaceutical Co. Ltd.
Zhuhai United Laboratories Co. Ltd.
Chapter 11 Appendix
Glossary
Baiyunshan Pharmaceutical General Factory
Guangzhou Baiyunshan Tianxin Pharmaceutical Co. Ltd.
Guangzhou Baiyunshan Guanghua Pharmaceutical Co. Ltd.
Baiyunshan Chemical Pharmaceutical Factory
Suzhou Dawnrays Pharmaceutical Co. Ltd.
Chinese Homegrown Drugmakers
foreign Drug Markets In the Chinese Market
Guangzhou Pharmaceutical
Harbin Pharmaceutical
North China Pharmaceutical
Yangtze River Pharmaceutical
Reyoung Pharmaceutical
Chiatai Tianqing
Hailingpharm
Pfizer
Gsk
Msd
Bayer Healthcare
List of Tables
Summary Table : Value of Chinese Infectious Disease Drug Market, By Disease Type, Through 2021
Table 1 : Value of Chinese Drug End-Consumer Market, By Sales Channels, Through 2021
Table 2 : Value of The Chinese Drug Market By Retail Channel By Drug Type, Through 2021
Table 3 : Chinese Retail Traditional Drugs Sales By Major Drug Type, 2015
Table 4 : Chinese Retail Traditional Patent Drug Sales By Drug Type, 2015
Table 5 : Chinese Retail Chemical And Biological Drug Sales By Drug Type, 2015
Table 6 : Chinese Drug Retail Sales By Retail Company, 2015
Table 7 : Value of The Chinese Drug Market In Hospitals, By Drug Type, Through 2021
Table 8 : Market Shares of Chinese Traditional Drugs Sold In Hospitals, By Hospital Type And Drug Type, 2015
Table 9 : Market Values of Chinese Traditional Drugs Sold In Hospitals, By Hospital Type And Drug Type, 2015
Table 10 : Market Values of Chinese Traditional Drugs Sold In Hospitals, By Hospital Type, Through 2021
Table 11 : Market Shares of Chemical And Biological Drugs Sold In Hospitals By Hospital Type And Drug Type, 2015
Table 12 : Market Value of Chemical And Biological Drugs Sold In Hospitals In 2015 By Hospital Type And Drug Type
Table 13 : Market Values of Chemical And Biological Drugs Sold In Hospitals By Hospital Type, Through 2021
Table 14 : Value of The Chinese Drug Market By Drug Type, Through 2021
Table 15 : Value of Chinese Traditional Drugs By Sales Channels Through 2021
Table 16 : Value of Chinese Chemical And Biological Drugs By Sales Channels, Through 2021
Table 17 : Value of The Chinese Infectious Disease Drug Market By Disease Type, Through 2021
Table 18 : Value of The Chinese Communicable Infectious Disease Drug Market By Major Disease Type, Through 2021
Table 19 : Number of Communicable Diseases By Major Type In China, 2015
Table 20 : Number of Chinese Category-A Communicable Diseases By Major Disease, 2015
Table 21 : Number of Chinese Category B Communicable Diseases By Major Disease, 2015
Table 22 : Number of Chinese Category C Communicable Diseases By Major Disease, 2015
Table 23 : Value of Chinese Viral Hepatitis Drug Market By Major Type, 2015
Table 24 : Value of Chinese Pulmonary Tuberculosis Drug Market By Major Type, 2015
Table 25 : Value of Chinese Infective Keratitis/Conjunctivitis Drug Market By Major Drug Type, 2015
Table 26 : Value of The Chinese Infectious Disease Drug Market By Major Product, Through 2021
Table 27 : Value of The Chinese Infectious Disease Drug Market By Major Product, Through 2021
Table 28 : Value of Chinese Entecavir Market By Sales Channel, 2015
Table 29 : Chinese Entecavir Market By Sales Channel And Leading Supplier, 2015
Table 30 : Value of Chinese Entecavir Market By Producers, 2015
Table 31 : Value of Chinese Injective Piperacillin-Tazobactam Market, By Sales Channel, 2015
Table 32 : Value of Chinese Injective Meropenem Market By Sales Channel, 2015
Table 33 : Value of Chinese Meropenem Market By Producers, 2015
Table 34 : Value of Chinese Injective Cefperazone-Sulbactam Market By Sales Channel, 2015
Table 35 : Value of Chinese Injective Cefperazone-Sulbactam Market By Producers, 2015
Table 36 : Value of Chinese Levofloxacin Market By Drug Form, 2015
Table 37 : Value of Chinese Injective Levofloxacin Market By Sales Channel, 2015
Table 38 : Value of Chinese Oral Levofloxacin Tablet Market By Sales Channel, 2015
Table 39 : Value of Chinese Injective Levofloxacin Market By Producers, 2015
Table 40 : Value of Chinese Injective Cefoperazone-Tazobactam Market By Sales Channel, 2015
Table 41 : Value of Chinese Cefuroximee Market By Producers, 2015
Table 42 : Value of Chinese Injective Cefuroximee Market By Sales Channel, 2015
Table 43 : Value of Chinese Injective Cefotiam Market By Sales Channel, 2015
Table 44 : Value of Chinese Cefotiam Market By Producers, 2015
Table 45 : Value of Chinese Injective Cefathiamidine Market By Sales Channel, 2015
Table 46 : Value of Chinese Cefathiamidine Market By Producers, 2015
Table 47 : Value of Chinese Injective Imipenem/Cilastatin Market By Sales Channel, 2015
Table 48 : Value of Chinese Imipenem/Cilastatin Market By Producers, 2015
Table 49 : Value of Chinese Voriconazole Market By Producers, 2015
Table 50 : Value of Chinese Injective Voriconazole Market By Sales Channel, 2015
Table 51 : Value of Chinese Voriconazole Market By Producers, 2015
Table 52 : Value of Chinese Moxifloxacin Market By Producers, 2015
Table 53 : Value of Chinese Moxifloxacin Market By Sales Channel, 2015
Table 54 : Value of Chinese Moxifloxacin Market By Producers, 2015
Table 55 : Value of Chinese Injective Cefoxitin Market By Sales Channel, 2015
Table 56 : Value of Chinese Cefoxitin Market By Producers, 2015
Table 57 : Value of Chinese Injective Latamoxef Market By Sales Channel, 2015
Table 58 : Value of Chinese Injective Latamoxef Market By Producers, 2015
Table 59 : Value of Chinese Injective Ceftriaxone Market By Sales Channel, 2015
Table 60 : Value of Chinese Ceftriaxone Market By Producer, 2015
Table 61 : Value of Chinese Adefovir Market By Sales Channel, 2015
Table 62 : Chinese Adefovir Market Share By Sales Channel And Leading Supplier, 2015
Table 63 : Value of Chinese Adefovir Market By Producers, 2015
Table 64 : Value of Chinese Lamivudine Market By Sales Channel, 2015
Table 65 : Chinese Lamivudine Market Share By Sales Channel And Leading Supplier, 2015
Table 66 : Value of Chinese Lamivudine Market By Producers, 2015
Table 67 : Value of Chinese Injective Cefazolin Market By Sales Channel, 2015
Table 68 : Value of Chinese Cefazolin Market By Producers, 2015
Table 69 : Value of Chinese Cefazolin Market By Producers, 2015
Table 70 : Value of Chinese Injective Ceftazidime Market By Sales Channel, 2015
Table 71 : Value of Chinese Ceftazidime Market By Producers, 2015
Table 72 : Value of Chinese Telbivudine Market By Sales Channel, 2015
Table 73 : Value of Chinese Cefixime Market By Drug Form, 2015
Table 74 : Value of Chinese Cefixime Market By Sales Channels, 2015
Table 75 : Value of Chinese Amoxicillin-Clavulanate Market By Producers, 2015
Table 76 : Value of Chinese Itraconazole Market By Drug Forms, 2015
Table 77 : Value of Chinese Itraconazole Market By Sales Channels, 2015
Table 78 : Value of Chinese Cefaclor Market By Drug Forms, 2015
Table 79 : Value of Chinese Cefaclor Market By Sales Channels, 2015
Table 80 : Value of Chinese Vidarabine Injection Market By Sales Channel, 2015
Table 81 : Chinese Vidarabine Market Share By Sales Channel And Leading Supplier, 2015
Table 82 : Value of Chinese Vidarabine Market By Producers, 2015
Table 83 : Value of Chinese Valacyclovir Tablet Market By Sales Channel, 2015
Table 84 : Value of Chinese Injective Ganciclovir Market By Sales Channel, 2015
Table 85 : Value of Chinese Injective Foscarnet Market By Sales Channel, 2015
Table 86 : Value of Chinese Oseltamivir Market By Sales Channel, 2015
Table 87 : Value of Chinese Ribavirin Market By Sales Channel, 2015
Table 88 : Value of Chinese Infectious Disease Drug Market By Producer Type, Through 2021
Table 89 : Chinese Infectious Disease Drug Marketby Producer Group, 2015
Table 90 : Chinese Homegrown Drugmakers And Their Sales In China, 2015
Table 91 : Guangzhou Pharmaceutical's Sales of Infectious Disease Drugs By Drug, 2015
Table 92 : Harbin Pharmaceutical's Sales of Infectious Disease Drugs By Drug, 2015
Table 93 : North China Pharmaceutical's Sales of Infectious Disease Drugs By Drug, 2015
Table 94 : Yangtze River Pharmaceutical's Sales of Infectious Disease Drugs By Drug, 2015
Table 95 : Chiatai Tianqing's Sales of Infectious Disease Drugs By Drug, 2015
Table 96 : Hailingpharm's Sales of Infectious Disease Drugs By Drug, 2015
Table 97 : Chinese Homegrown Drugmakers And Their Sales In China, 2015
Table 98 : Pfizer's Sales of Infectious Disease Drugs By Drug, 2015
Table 99 : Gsk's Sales of Infectious Disease Drugs By Drug, 2015
Table 100 : Msd's Sales of Infectious Disease Drugs By Drug, 2015
Table 101 : Bayer Healthcare's Sales of Infectious Disease Drugs By Drug, 2015
Table 102 : Value of The Chinese Infectious Disease Drug Market By Sales Channels, Through 2021
Table 103 : Chinese Retail Drug Market, By Retailers, 2015
Table 104 : Chinese Retail Drug Market By Drug Product, 2015
Table 105 : Chinese Retail Cefixime Market By Drug Form, 2015
Table 106 : Chinese Retail Entercavir Market By Drug Form, 2015
Table 107 : Chinese Retail Adeforvir Market By Drug Form, 2015
Table 108 : Chinese Market Values of Infectious Disease Drugs Sold In Hospitals By Hospital Type, Through 2021
Table 109 : Number of Hospitals In China By Type, 2015
Table 110 : Number of City And County Hospitals In China By Type, 2015
Table 111 : Number of City And County Hospitals In China By Ownership, 2015
Table 112 : Number of City And County Hospitals In China By Type, 2015
Table 113 : Value of The Chinese Infectious Disease Drug Market By Major Region, Through 2021
Table 114 : Values of The North China Infectious Disease Drug Market By Province, Through 2021
Table 115 : Values of Infectious Disease Drugs, Population And Average Consumption In North China Market By Province, 2015
Table 116 : Values of The East China Infectious Disease Drug Market By Province, Through 2021
Table 117 : Values of Infectious Disease Drugs, Population And Average Consumption In East China Market By Province, 2015
Table 118 : Values of The South China Infectious Disease Drug Market By Province, Through 2021
Table 119 : Values of Infectious Disease Drugs, Population And Average Consumption In The South China Market By Province, 2015
Table 120 : Values of The Middle China Infectious Disease Drug Market By Province, Through 2021
Table 121 : Values of Infectious Disease Drugs, Population And Average Consumption In The Middle China Market By Province, 2015
Table 122 : Values of The Northwest China Infectious Disease Drug Market By Province, Through 2021
Table 123 : Values of Infectious Disease Drugs, Population And Average Consumption In The Northwest China Market By Province, 2015
Table 124 : Values of The Southwest China Infectious Disease Drug Market By Province, Through 2021
Table 125 : Values of Infectious Disease Drugs, Population And Average Consumption In The Southwest China Market By Province, 2015
Table 126 : Values of The Northeast China Infectious Disease Drug Market By Province, Through 2021
Table 127 : Values of Infectious Disease Drugs, Population And Average Consumption In The Northeast China Market By Province, 2015
Table 128 : Value of The Chinese Infectious Disease Drug Market By Major Product, Through 2021
List of Figures
Summary Figure : Value of Chinese Infectious Disease Drug Market, By Disease Type, 2015-2021
Figure 1 : Value of Chinese Drug End-Consumer Market, By Sales Channels, 2015-2021
Figure 2 : Drug Supply Chain In China
Figure 3 : Value of The Chinese Communicable Infectious Disease Drug Market By Major Disease Type, 2015-2021
Figure 4 : Value of The Chinese Communicable Infectious Disease Drug Market By Major Disease Type, 2015-2021
Figure 5 : Value of The Chinese Communicable Infectious Disease Drug Market By Major Disease Type, 2015-2021
Figure 6 : Value of Chinese Entecavir Market By Sales Channel, 2015
Figure 7 : Value of Chinese Injective Piperacillin-Tazobactam Market, By Sales Channel, 2015
Figure 8 : Value of Chinese Injective Meropenem Market By Sales Channel, 2015
Figure 9 : Value of Chinese Injective Cefperazone-Sulbactam Market By Sales Channel, 2015
Figure 10 : Value of Chinese Injective Levofloxacin Market By Sales Channel, 2015
Figure 11 : Value of Chinese Injective Cefoperazone-Tazobactam Market By Sales Channel, 2015
Figure 12 : Value of Chinese Injective Cefuroxime Market By Sales Channel, 2015
Figure 13 : Value of Chinese Injective Cefotiam Market By Sales Channel, 2015
Figure 14 : Value of Chinese Injective Cefathiamidine Market By Sales Channel, 2015
Figure 15 : Value of Chinese Injective Imipenem/Cilastatin Market By Sales Channel, 2015
Figure 16 : Value of Chinese Injective Voriconazole Market By Sales Channel, 2015
Figure 17 : Value of Chinese Moxifloxacin Market By Sales Channel, 2015
Figure 18 : Value of Chinese Injective Cefoxitin Market By Sales Channel, 2015
Figure 19 : Value of Chinese Injective Latamoxef Market By Sales Channel, 2015
Figure 20 : Value of Chinese Injective Ceftriaxone Market By Sales Channel, 2015
Figure 21 : Value of Chinese Adefovir Market By Sales Channel, 2015
Figure 22 : Value of Chinese Lamivudine Market By Sales Channel, 2015
Figure 23 : Value of Chinese Injective Cefazolin Market By Sales Channel, 2015
Figure 24 : Value of Chinese Injective Ceftazidime Market By Sales Channel, 2015
Figure 25 : Value of Chinese Telbivudine Market By Sales Channel, 2015
Figure 26 : Value of Chinese Vidarabine Market By Sales Channel, 2015
Figure 27 : Value of Chinese Valacyclovir Market By Sales Channel, 2015
Figure 28 : Value of Chinese Ganciclovir Market By Sales Channel, 2015
Figure 29 : Value of Chinese Foscarnet Market By Sales Channel, 2015
Figure 30 : Value of Chinese Oseltamivir Market By Sales Channel, 2015
Figure 31 : Value of Chinese Ribavirin Market By Sales Channel, 2015
Figure 32 : Value of Chinese Infectious Disease Drug Market By Producer Type, 2015-2021
Figure 33 : Value of Chinese Infectious Disease Drug Market By Sales Channels, 2015-2021
Figure 34 : Value of The Chinese Communicable Infectious Disease Drug Market By Major Region, 2015-2021
Figure 35 : Drug Supply Chain In China
Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 87
The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
Global Esomeprazole Magnesium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 74
The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030.
North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
Global Combination Therapy Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
Global Axitinib Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 68
The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
Global Lyme Disease Vaccine Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 70
The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi.
The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at......
Global Transdermal Absorption Patch Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
Global Ketoprofen Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis
The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
Global Methyl Salicylate Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 82
The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
Global Diclofenac Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
